DV Biomed Co., Ltd.(TW:6539)
NT$36.200.00 (0.00%)
TW:6539
DV Biomed Co., Ltd. financials statements
NT$36.20
At close:0.00 (0.00%)
DV Biomed Co., Ltd. (6539) Income Statement
DV Biomed Co., Ltd. Income Statement
Last quarter (Q2 2026), DV Biomed Co., Ltd.'s total revenue was NT$194.38M, an increase of 0.26% from the same quarter last year. In Q2, DV Biomed Co., Ltd.'s net income was NT$28.73M. See DV Biomed Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 794.18M | NT$ 573.57M | NT$ 1.54B | NT$ 1.87B | NT$ 1.83B | |
| NT$ 566.63M | NT$ 424.50M | NT$ 764.28M | NT$ 1.04B | NT$ 1.02B | |
| NT$ 551.77M | NT$ 316.17M | NT$ 333.28M | NT$ 652.56M | NT$ 605.36M | |
| Depreciation and Amortization | NT$ 35.42M | NT$ 18.89M | NT$ 24.59M | NT$ 183.58M | NT$ 182.66M |
| NT$ 50.27M | NT$ 146.38M | NT$ 185.88M | NT$ 582.63M | NT$ 610.85M | |
| NT$ 14.86M | NT$ 108.33M | NT$ 148.96M | NT$ 386.31M | NT$ 416.86M | |
| NT$ -4.75M | NT$ 16.18M | NT$ 12.17M | NT$ -21.86M | NT$ -22.89M | |
| NT$ 10.11M | NT$ 125.81M | NT$ 161.13M | NT$ 365.06M | NT$ 395.76M | |
| NT$ 7.74M | NT$ 89.08M | NT$ 162.91M | NT$ 281.26M | NT$ 304.57M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 0.32 | NT$ 4.18 | NT$ 7.90 | NT$ 11.52 | NT$ 12.38 |
| Diluted EPS | NT$ 0.32 | NT$ 4.18 | NT$ 7.89 | NT$ 11.49 | NT$ 12.35 |
| Weighted Average Shares Outstanding | 24.18M | 20.64M | 20.63M | 20.70M | 20.86M |
| Weighted Average Shares Outstanding (Diluted) | 24.18M | 20.66M | 20.65M | 20.73M | 20.86M |
Currency in TWD

